REF 2029 Timeline: Panel Criteria to Submission
REF 2029 runs from panel criteria consultation to the autumn 2028 submission deadline and December 2029 results.
Editorial · Newsdesk
Briefings on the external policy landscape — funder mandates, AI regulation, national assessment exercises, and open-science requirements — reported for the global research-administration community.
REF 2029 runs from panel criteria consultation to the autumn 2028 submission deadline and December 2029 results.
REF 2029’s pause ended 10 Dec 2025. See what changed, and what the 2026 panel restart means for institutional planning.
UK, US and EU rules for national research data repositories differ on FAIR compliance — here’s how the mandates compare.
cOAlition S has ended transformative-agreement funding, redirecting money to diamond OA and repositories.
A 2026 status check on cOAlition S: which funder members still mandate immediate open access, and which have relaxed enforcement.
cOAlition S’s new 2026-2030 strategy ends default support for transformative agreements, redirecting funding toward diamond open access.
AIRIA stalled in the US Senate, but its risk-based rules now echo in state AI laws and NIH/NSF grant compliance.
US state AI laws are multiplying without federal preemption, creating a compliance patchwork for multi-campus research consortia.
How the UK, US, EU, Japan, Korea, Singapore and Canada jointly test frontier AI models before deployment.
EU Digital Omnibus delays AI Act regulatory sandbox deadlines to 2027 — here’s what it means for university AI pilots.
The Digital Omnibus delays AI Act high-risk rules to 2027-28; sandboxes shift to Aug 2027. Here’s what still applies in 2026.
UK research funding volatility in 2026 explained: UKRI’s funding buckets, grant pauses, and what research offices should do next.
UKRI’s £60m SOFAIR and BOLD AI labs signal a shift to fundamental research and staged funding for grant applicants.
UK R&D funding rises to £55.4bn by 2029/30 — what it means for institutional grant pipelines.
UKRI’s £38.6bn budget is now split into four funding buckets — here’s what changes for grant holders through 2030.
Clarivate closes Research Professional News on 31 December 2026 — here is how UK research offices should replace its coverage.
A binding AI treaty runs alongside the EU AI Act, covering Council of Europe states such as the UK.
Canada’s Tri-Agency RDM Policy sets institutional, DMP and data-deposit duties for CIHR, NSERC and SSHRC grantees.
OECD’s companion paper maps research-assessment reform actors and tensions — separate from its flagship report.
Cluster 6 layers biodiversity data-sharing duties onto Horizon Europe’s standard open data rules — what changes for 2026 applicants.
The UK’s Horizon Europe association holds into 2026, with UK grantees bound by the same open access and data mandates as EU institutions.
FP10 proposes replacing Horizon Europe’s three pillars with four, adding a dedicated European Research Area pillar.
The EC’s FP10 proposal sets a €175bn Horizon Europe budget for 2028-2034 inside a new EU Competitiveness Fund.
Parliament wants €200bn for FP10 vs the Commission’s €175bn. What the standoff means for grant-pipeline planning.
UKRI revised its research and training grant terms and conditions for 2025-26, changing stipends, equipment costing, and security compliance rules.
What changed in UKRI’s Global Talent visa route in 2026 — and why the £54m Global Talent Fund has sparked concern among excluded institutions.
UKRI Future Leaders Fellowships Round 11 runs 2 Feb-16 June 2026. Here is what changed in eligibility and timing versus Round 10.
REF 2029 panel members were recruited by open application, for the first time — here is who is now setting the assessment criteria.
REF 2029 decouples outputs from staff, ending automatic portability except a 5-year carve-out for books. Here is what changed.
How NIH, Wellcome and the Gates Foundation treat bioRxiv and medRxiv preprints differently under their 2026 open access policies.
bioRxiv’s Author Area now lets authors switch to a less-restrictive licence on existing preprints. Here is what changed.
How NIH-funded bioRxiv and medRxiv preprints reach PubMed via the NIH Preprint Pilot, and what other funders are watching.
UKRI’s ODA research budget has faced repeated cuts since 2021, with more reductions to 2027 — what grant holders need to know.
MRC paused grant schemes in 2026 – here’s which UKRI opportunities reopened and what changed for grant holders.
Lehigh’s research misconduct policy takes effect 1 January 2026, part of a wider wave of US university policy updates under a revised federal rule.
Wellcome funds APCs directly, mandates CC BY with zero embargo, and pre-dates Plan S by over a decade.
The Gates Foundation stopped paying APCs from 1 January 2025 and mandated preprints for all funded manuscripts.
How the EU AI Act, US state laws, China’s rules and the Council of Europe treaty create friction for research consortia.
The UK rejected a broad AI text and data mining exception in 2026 — what stays the same for research libraries.
China’s Interim AI Measures reshape joint authorship, data-sharing and co-supervision — compared against EU, UK and US rules.
The UK’s £500m Sovereign AI Fund backs startups, not universities — here’s how research groups access AIRR compute and UKRI funding instead.
One year on, what the AI Opportunities Action Plan delivered for UK university research — and what has stalled.
The UK’s AI Safety Institute was renamed AI Security Institute in 2025. Here’s what changed and what it means for universities.
How UK association to Horizon Europe actually works: eligibility routes, the guarantee wind-down, and the EU correction mechanism explained.
UK clinical trial regulations changed 28 April 2026. What research offices must know and do now.
NIH now runs two grant application caps at once: a 6-per-year submission limit and a new proposal to cap concurrent awards.
UKRI’s 2026 call opens 50 policy fellowships across 26 government partners, with new rules for secondment agreements.
A timeline of NIH and HHS grant terminations, court-ordered restorations, and how research offices can monitor exposure via RePORTER.
NIH lifted its hold on frozen South Africa grants in 2025 — here’s what changed and what subawardees should track.
The multi-state NIH indirect cost cap lawsuit concluded in April 2026 when the administration dropped its Supreme Court appeal after a First Circuit loss.
ORI’s Final Rule takes effect in 2026: here is what institutions must submit for annual assurance renewal, and by when.
Vietnam’s new tiered rules pair funding bans with public apologies — a live test case for graduated research-misconduct sanctions.
Scotland’s SFC approved a new research integrity policy in May 2026. Here is what changes for misconduct reporting from September 2026.
cOAlition S recommends — but does not mandate — open access for monographs, diverging sharply from the binding Horizon Europe rules.
cOAlition S narrowed Plan S’s all-funder open access mandate for 2026-2030. Here is what changed, and what it means for institutions.
New 2026 chip-export rules are reshaping university GPU procurement and international co-authorship agreements.
DSIT’s AI Growth Lab proposes supervised regulatory sandboxes for AI. Here’s what the sandbox pilots could mean for university research offices.
NIH’s NOT-OD-25-132 bars AI-drafted grant applications and caps PIs at six submissions a year — here is what compliance actually requires.
Compare ERC, NIH, UKRI and NHMRC 2025-26 AI peer-review rules and get reviewer-agreement clauses.
OMB’s 2026 proposed rule reshapes 2 CFR 200 Subpart E cost allowability. Here is what changes and why it matters.
Harvard, Columbia and multi-state lawsuits are reshaping how NIH and NSF terminate and review grants.
HHS and BARDA’s $500m mRNA wind-down is reshaping institutional funding portfolios — here is what changed and who is affected.
NIH has terminated 1,392 cancer-related awards worth $539M by April 2026. See what the data shows and how institutions can respond.
OMB’s 2026 proposed grants rule would make grant peer review advisory and widen political termination power over federal awards.
OMB’s proposed 2026 rewrite of 2 CFR 200/300 tightens oversight, termination and cost rules — comments close 13 July 2026.
NIH’s revised DMS Plan format takes effect May 2026, adding sharper metadata and preservation detail requirements to grant applications.
UKRI’s Funding Service consolidation reshapes application routes and reporting data — here’s what research offices must do before the 2026 cycle.
A neutral, aggregate recap of how European data-protection authorities applied the GDPR through 2025 — the recurring themes in enforcement, the role of the one-stop-shop and EDPB coordination, and the principles regulators emphasised, without naming specific cases as accusations.
The EU Clinical Trials Regulation is now in full force, with the Clinical Trials Information System the mandatory single entry point for trial applications across the EU and EEA. This explainer describes harmonised authorisation, the role of CTIS and the end of the transition period.
ICH E6(R3) modernises the international Good Clinical Practice guideline around quality-by-design, risk-based thinking and flexibility for diverse trial designs and technologies. This explainer describes what the revised GCP guideline emphasises and how it differs in spirit from the earlier E6(R2).
NSPM-33 directs US federal research agencies to standardise disclosure requirements and asks covered institutions to maintain research-security programmes. This explainer describes the disclosure expectations, the four programme elements and how research security relates to the fundamental-research exclusion.
The US Office of Management and Budget’s 2024 revisions to the Uniform Guidance raised the Single Audit threshold to $1 million and lifted the de-minimis indirect-cost rate to 15 percent. This explainer summarises what research administrators should understand about the updated grants-management rules.
The 2022 OSTP guidance known as the Nelson memo directed US federal agencies to make funded publications and supporting data free to read, with full implementation expected by the end of 2025. This explainer describes the memo, the end-2025 milestone, and how agency rollouts took shape.
From mid-2025, peer-reviewed papers arising from NIH funding became freely available in PubMed Central immediately on publication, ending the previous twelve-month embargo. This explainer describes what the updated policy changed, who it applies to, and how authors and administrators interpret the new immediate-access requirement.
The Texas Responsible AI Governance Act took effect on 1 January 2026, adding to a fast-growing patchwork of US state AI laws. A neutral explainer of TRAIGA and how state approaches differ.
New York City’s Local Law 144 requires annual independent bias audits of automated employment decision tools. A neutral explainer of what the audit involves and the notice and publication duties.
Colorado’s SB24-205 was the first comprehensive US state law targeting algorithmic discrimination in high-risk AI. A neutral explainer of its scope and its repeatedly deferred effective date.
The EU AI Act’s high-risk obligations centre on conformity assessment and CE marking. A 2 August 2026 milestone, plus later phased dates and a proposed deferral, shape the compliance calendar.
From 2 August 2025, the EU AI Act’s obligations for general-purpose AI model providers began to apply, accompanied by a voluntary GPAI Code of Practice covering transparency, copyright and safety.
From 2 February 2025, the EU AI Act’s bans on certain AI uses under Article 5 began to apply, alongside a new AI-literacy duty under Article 4 for providers and deployers across the Union.
Eighteen months after NSPM-33 disclosure requirements took effect, a status report on what worked, what is broken, and the institutional adjustments still pending.